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Purpose: The present study aims to explore the extent to which gender, epilepsy severity and
illness perceptions predict fatigue and sleep problems in youngsters with epilepsy.
Method: Structured interviews were conducted in 100 young patients (Mage ¼ 13,9,
SD ¼ 2.21; 41% girls) and data were analyzed by means of multiple hierarchical regression
analyses.
Results: Most patients (91%) were well controlled by anti-epileptics; 3% had infrequent
seizures and 6% were pharmacoresistant. At a multivariate level it appeared that young-
sters with epilepsy who believe that they have less personal control over their illness and
who feel that the illness has a high emotional impact on their lives reported higher levels of
fatigue. In addition, more sleep problems were reported by youngsters who think they have
less personal control over the disease, who believe that treatment controls epilepsy and
report that the disease has a high emotional impact on their lives.
Conclusion: Given the importance of illness perceptions, it is suggested that they are targets for
future interventions thataimtoreduce fatigueandsleepproblems inyoungsterswithepilepsy.
© 2015 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights
reserved.1. Introduction
Fatigue and sleep problems are frequently reported as a
burden by youngsters with epilepsy, but there are few studiesens, Greece. Tel.: þ30 69
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logy Society. Published bthat have explored the cause of these symptoms.1e4 As there
is evidence that illness perceptions next to disease charac-
teristics may be important determinants of somatic symp-
toms,1 the present study investigates the influence of illness45461024.
.leidenuniv.nl (V. De Gucht), theon@otenet.gr (A. Papavasiliou),
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e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 2 0 ( 2 0 1 6 ) 9 3e9 994cognitions on fatigue and sleep problems in youngsters with
epilepsy.
Fatigue and sleep problems appear to share some common
features. They can both be considered as symptoms of a
psychological problems and/or physical illness, as side effects
of medication (i.e. antiepileptic drugs), or as a separate entity
(i.e. chronic fatigue syndrome). Due to the fact that (a) these
symptoms have a multidimensional nature, b) their appear-
ance may be transient but may also become chronic, and c)
their etiology cannot be fully explained by organic findings, it
is very difficult to define, diagnose and measure them in an
adult population, and even more difficult in youngsters with
epilepsy.1,4e12 Especially in epilepsy, fatigue and sleep prob-
lems can have seizure-provoking effects, but at the same time,
frequent seizures may in turn lead to their appearance.
Without intervention, this vicious cycle of events may lead to
impairment in all aspects of daily functioning.2,13e15
Research in children and adolescents with epilepsy points
at the fact that girls and older children/adolescents tend to
report a worse overall quality of life and more feelings of
distress.16,17 In addition, girls, older adolescents and those
with more severe epilepsy tend to report more negative atti-
tudes toward their epilepsy than boys, younger adolescents
and those with moderate or mild epilepsy.18,19 Research in
non-epileptic adolescents suggests that girls usually report
higher levels of fatigue and sleep problems than boys.13,20
Furthermore, there are several studies showing that dis-
ease severity, type of seizure, unpredictability, recurrence and
high frequency of seizures, longer duration of disease and
some anti-epileptic drugs are linked to depression and
reduced quality of life in adolescents with epilepsy.21 Higher
fatigue scores have been reported in adult patients with a
longer duration of epilepsy and in tertiary epilepsy patients.22
Another study suggested that the most important causes of
fatigue in adult epilepsy patients were a) energy consumption
due to the number of seizures and b) the type of seizures,
namely, generalized tonic-clonic seizures.3 Sleep disorders in
adolescents with epilepsy have been linked with paroxysmal
activity density, longer duration of epilepsy and higher seizure
frequency.15,23 All types of seizures are believed to have the
potential to cause adverse effects on sleep.24 Lastly, it has
been shown that behavioral problems in children are more
directly related to the existence of a concomitant sleep
disturbance than to the severity of their epilepsy.14
Leventhal's Self-Regulation Theory (SRT) particularly fo-
cuses on the role of illness perceptions or beliefs in illness
behavior and the experience of symptoms. Important attri-
butes of illness perceptions are according to this theory:
identity (the name or label given to the illness or symptoms),
timeline (the perceived time trajectory of the illness), conse-
quences (the expected future effects and outcomes of the
illness), cause (the supposed etiology of the illness) and cure or
control (the extent to which the patients believe that they may
recover or have personal control over the illness). Finally,
emotional representations of the illness incorporate anticipated
negative emotional reactions such as anger, fear, and distress
due to the presence of the disease.1,25e28 Although there is
evidence suggesting that illness perceptions also play an
important role in the way children or adolescents experience
and cope with a chronic disease,1 as well as to their quality oflife and psychological distress29 to our knowledge there is no
research on the link between illness perceptions and fatigue
and/or sleep problems in youngsters with epilepsy.
The present study explores whether, after controlling for
gender and epilepsy severity, illness perceptions explain
important parts of the variance in fatigue and sleep problems
in youngsters with epilepsy. We hypothesize that a) female
gender and more severe types of epilepsy will be positively
related to fatigue and sleep problems and b) perceptions of
control will be negatively related to fatigue and sleep prob-
lems, while all other illness cognitions will reveal an opposite
relationship.2. Material and methods
2.1. Study design and patient recruitment
The present cross-sectional studywas approved by the Ethical
Research Committee of Pendeli's Children Hospital. Partici-
pants were recruited between March 2009 and January 2012
according to the following inclusion criteria: 1) age: 10e18
years old, 2) at least one epileptic seizure during the preceding
year, 3) normal IQ, 4) no other chronic illness, physical
disability, ormental disorder, 5) no surgical procedures during
the preceding year, and 6) no medication change in the last 6
months.
Four hundred medical records of youngsters were
consecutively examined at the Epilepsy Clinic and reviewed
for their eligibility for the study. After examination of the
medical records by a neurologist, 200 youngsters who fulfilled
the inclusion criteria were approached during their pre-
scheduled visits. The first 100 who agreed to participate were
included in the present study.
Initially, parents were informed about the goals and pro-
cedures of the study by the treating neurologist. Subsequently
a meeting with the parents and the young patient was plan-
ned to explain the study in more detail. The first 100 of them
who agreed to participate and signed an informed consent
form and were included in the study. Next, all questionnaires
were completed by the patient, without presence of the par-
ents, in the context of an interview. The interviewer did not
know any of the patients prior to this meeting and always
asked the exact same questions following a protocol. The
interview lasted approximately 60e70 min.
2.2. Measures
2.2.1. Disease characteristics
Data regarding disease characteristics were derived from the
medical records and included type of epilepsy, duration, age of
onset, time of last seizure, total number of seizures and
medication. The severity of epilepsy was evaluated on an
ordinal scale with 6 categories. Starting from the least severe
epilepsy, the categories were: 1) benign focal childhood epi-
lepsy, 2) idiopathic generalized epilepsy, 3) epilepsy well
controlled by medication but with unknown prognosis (un-
known etiology of epilepsy), 4) symptomatic epilepsy with
adequate response to medication (more than 6 months
seizure free), 5) symptomatic epilepsy with moderate
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e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 2 0 ( 2 0 1 6 ) 9 3e9 9 95response to medication (less than 6 months seizure free), and
6) pharmaco-resistance (failure to respond to at least 3
appropriately selected anti-epileptics).30 In the present study,
this severity scale was used in the analyses with lower scores
indicating less severe epilepsy.
All data, except for disease characteristics, were obtained
by means of the following validated questionnaires:
2.2.2. Illness perceptions
2.2.2.1. Brief illness perceptions questionnaire (BIPQ)25. Seven
items measure cognitive illness representations (conse-
quences, timeline, identity, personal and treatment control)
and emotional representations (concern and emotion). An
additional item asks the patient to mention factors that ac-
cording to his/her opinion caused the illness. A 10-point Likert
scale is used to answer each itemwith lower scores indicating
more beneficial perceptions (i.e. for timeline: 0 ¼my epilepsy
will last for a very short time to 10¼ it will last forever), except
for coherence, personal and treatment control, where higher
scores represent more beneficial perceptions. In order to
compute the total score, the scores of these items are reversed
and therefore in all items a lower score reflects a less threat-
ening view of the illness.
2.2.3. Checklist individual strength (CIS) questionnaire31,32
Fatigue is measured via 20 statements where the participant
indicates on a 7-point Likert scale to what extent each
particular statement applies to him/her. The subscales of this
questionnaire are a) subjective feeling of fatigue (8 items), b)
concentration (5 items), c) motivation (4 items), and d) physical
activity (3 items). The total score is calculated by adding up the
scores for each dimension. Higher scores indicate higher
levels of fatigue severity. Normative values for healthy sub-
jects were used to interpret the scores of our population.31 As
indicated, a cut-off of 35 for the main dimension (subjective
feeling of fatigue)was used to define clinical levels of fatigue.33
2.2.4. Athens insomnia scale (AIS)34,35
This is an instrument designed to quantify sleep difficulty
which consists of 8 items that refer to sleep induction,
awakenings during the night, final awakening, total sleep
duration, sleep quality, well-being, functioning capacity, and
sleepiness during the day. Each item can be rated 0e3 (with
0 corresponding to “no problem at all” and 3 “very serious
problem”). A total score is calculated by adding up the scores
for each item. Higher scores indicate more sleep problems. A
cut-off of 6 for the total score was used to define clinical levels
of insomnia.35
2.3. Statistical analysis
With respect to patient characteristics, categorical data were
described as numbers and percentages. Preliminary analyses
were carried out, using Pearson's correlations, in order to
examine the univariate relationships between all the vari-
ables used in the present study (Table 1). Second, in order to
compare our scores with the normative samples two new
dichotomous variables were created. A new variable for sub-
jective fatiguewas created based on the cut-off point of 3531 in
order to distinguish between normal and clinical levels of
e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 2 0 ( 2 0 1 6 ) 9 3e9 996fatigue. In addition, another dichotomous variable based on
the cut-off of 635 was created in order to distinguish between
normal and clinical levels of sleep problems. After selecting
only the participants who reported normal levels of fatigue, a
one-sample T-test was performed with subjective fatigue
being the test variable, and the mean for the normative
sample (17.30) reported by Vercoulen et al. (1999) being the test
value.31 Similarly, after selecting only the participants who
reported normal levels of sleep problems, a one-sample T-test
was performed with sleep problems being the test variable,
and the mean for the normative sample (2.28) reported by
Soldatos, Dikeos & Paparrigopoulos (2003) being the test
value.35 Lastly, separate multiple hierarchical regression an-
alyses were conducted for each outcome. Both for fatigue and
sleep problems, in the first block, gender was entered in the
analysis (model 1). In the second block, severity was entered
(model 2). Lastly, in the third block, illness perceptions were
added (model 3).3. Results
3.1. Patients
The 100 participants in our study had a mean age of 13.9
(SD ¼ 2.21) and 59% of them were boys. Regarding epilepsy
severity, 6% of these patients fulfilled criteria for pharmaco-
resistance, 3% were less than 6 months seizure-free (symp-
tomatic epilepsy with moderate response to medication), 24%
were more than 6 months seizure-free (symptomatic epilepsy
with adequate response to medication), 14% were well
controlled by medication but with unknown prognosis, 30%
had idiopathic generalized epilepsy, and 23% benign focal
childhood epilepsy.3.2. Comparisons of scores between youngsters with
epilepsy and normative samples
As shown in Table 2, themean score on subjective fatigue was
significantly lower than the normative sample of healthy
subjects.31 In the present study, 11% of the respondents
reached the clinical cut-off score. In addition, the mean score
on sleep problems was significantly lower than the normative
sample of healthy subjects.35 In the present study, 33% of the
respondents reached the clinical cut-off score.Table 2 e Comparison of fatigue and sleep problems of
this study with normative data and the number of
respondents reaching the clinical cutoffs.
Mean
(SD)
Sig Cutoff Clinical
level (%)
Subjective Fatigue
Youngsters with epilepsy 14.89 (7.03) 0.002 35 11%
Normative sample 17.30 (10.10)
Sleep problems
Youngsters with epilepsy 0.73 (1.23) 0.000 6 33%
Normative sample 2.28 (2.56)3.3. Hierarchical regression analyses
3.3.1. Predicting fatigue
The results of the hierarchical regression analysis with fatigue
as the dependent variable are shown in Table 3. The final
model (model 3: R2 ¼ 0.302, adjusted R2 ¼ 0.224, F ¼ 3.850,
df ¼ 10, p < 0.001) shows that thinking to have less personal
control over your illness and thinking that epilepsywill have a
high emotional impact on your life predicts higher levels of
fatigue in youngsters with epilepsy.
3.3.2. Predicting sleep problems
As presented in Table 4, the final model (model 3: R2 ¼ 0.365,
adjusted R2 ¼ 0.293, F ¼ 5.109, df ¼ 10, p < 0.001) shows that
thinking to have less personal control over your disease,
thinking that control over your disease is dependent on others
and thinking that epilepsy will have a high emotional impact
on your life will predict more sleep problems in youngsters
with epilepsy.4. Discussion
The present study investigated the extent to which gender,
epilepsy severity and illness perceptions predict fatigue and
sleep problems in youngsters with epilepsy. Overall, our
findings provide support for the predictive power of illness
perceptions on fatigue and sleep problems, concepts that have
not being investigated extensively in the adolescent epilepsy
literature.
In our study, preliminary analyses revealed significant
positive association between sleep problems and fatigue
(r ¼ 0.650, p < 0.001). This relatively high correlation is how-
ever most probably rather due to a cause effect relationship
than to large concept overlap. Although both outcomes may
thus be related, they should not be treated as identical
problems.36,37
The comparison between our patients with normative
groups revealed that youngsters with epilepsy had signifi-
cantly lower levels of fatigue and sleep problems than the
normative group (Table 2). A possible explanation for this
finding could be the fact that the normative groups were
derived from adult populations. This finding is not in line with
studies that suggest that children with epilepsy show much
higher rates of sleep disorders than healthy controls, but it
should be noted that in this study sleep problems were
assessed using parental questionnaires, while in our study
self-reports by youngsters were used.38 It is quite clear that
there is a need for normative fatigue data, derived from a
study in healthy youngsters. While the percentage of young-
sters reaching clinical levels in this study is thus probably an
underestimation, one third of our study population reported
clinical levels of sleep problems.
The results of the final multiple regression model with fa-
tigue as the dependent variable (R2 ¼ 0.302, adjusted
R2 ¼ 0.224, F ¼ 3.850, df ¼ 10, p < 0.001) shows that thinking to
have less personal control over the disease and believing that
epilepsy has a high emotional impact on life predict higher
levels of fatigue in youngsters with epilepsy. This suggests
Table 3 e Summary of hierarchic regression analysis for variables associated with fatigue of adolescents with epilepsy
(N ¼ 100).
Model 1 Model 2 Model 3
B (b) SE B p B (b) SE B p B (b) SE B p
Gender 13.012 (0.314) 3.974 0.00 12.870 (0.311) 3.948 0.00 7.789 (0.188) 4.402 0.08
Severity 2.166 (0.146) 1.418 0.13 1.073 (0.072) 1.485 0.47
Consequences 2.020 (- 0.327) 1.074 0.06
Timeline 1.487 (0.213) 1.028 0.15
Personal control 3.511 (0.370) 1.774 0.05
Treatment control 3.432 (0.315) 1.953 0.08
Identity 0.140 (0.016) 1.180 0.91
Concern 1.974 (0.265) 1.110 0.08
Coherence 0.402 (0.045) 1.029 0.70
Emotional representation 2.262 (0.337) 1.130 0.05
Model 1: R2 ¼ 0.099, adjusted R2 ¼ 0.089, F ¼ 10.721, df ¼ 1, p < 0.001.
Model 2: R2 ¼ 0.120, adjusted R2 ¼ 0.102, F ¼ 6.599, df ¼ 2, p < 0.001.
Model 3: R2 ¼ 0.302, adjusted R2 ¼ 0.224, F ¼ 3.850, df ¼ 10, p < 0.001.
Table 4 e Summary of hierarchic regression analysis with gender, disease severity and illness perceptions as independent
variables and sleep problems as the dependent variable in adolescents with epilepsy (N ¼ 100).
Model 1 Model 2 Model 3
B (b) SE B p B (b) SE B p B (b) SE B p
Gender 1.357 (0.197) 0.197 0.05 1.349 (0.196) 0.685 0.05 0.183 (0.027) 0.698 0.79
Severity 0.113 (0.045) 0.246 0.65 0.040 (0.016) 0.236 0.86
Consequences - 0.034 (- 0.033) 0.170 0.84
Timeline 0.193 (0.166) 0.163 0.24
Personal control 0.955 (0.606) 0.281 0.00
Treatment control 0.877 (0.484) 0.310 0.01
Identity 0.176 (0.120) 1.187 0.35
Concern 0.143 (0.116) 1.176 0.42
Coherence 0.178 (0.119) 0.163 0.28
Emotional representation 0.502 (0.450) 1.179 0.01
Model 1: R2 ¼ 0.039, adjusted R2 ¼ 0.029, F ¼ 3.955, df ¼ 1, p < 0.05.
Model 2: R2 ¼ 0.041, adjusted R2 ¼ 0.021, F ¼ 2.066, df ¼ 2, n.s.
Model 3: R2 ¼ 0.365, adjusted R2 ¼ 0.293, F ¼ 5.109, df ¼ 10, p < 0.001.
e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 2 0 ( 2 0 1 6 ) 9 3e9 9 97that illness cognitions may have an exacerbating effect on
symptoms or in other words amplify the severity of the pa-
tients' illness experience.
The final multiple regression model with sleep problems
as the dependent variable (R2 ¼ 0.365, adjusted R2 ¼ 0.293,
F ¼ 5.109, df ¼ 10, p < 0.001) shows that thinking to have less
personal control over epilepsy, thinking to be dependent on
others for the control of the disease and believing that ep-
ilepsy has a high emotional impact on your life predict
more sleep problems in youngsters with epilepsy. This
suggests that a passive, dependent or emotional way of
coping with the disease may result in an aggravation of
sleep problems.
In both regression analyses gender was initially a signifi-
cant predictor, suggesting that being a girl significantly pre-
dicts higher levels of fatigue and more sleep problems. This
relationship disappeared however, when illness perceptions
were added to the analyses, suggesting that illness percep-
tions rule out the effect of gender. The literature delineating
the link between gender and fatigue is however discordant,
supported by some,39 but not by others.1Severity of epilepsy was not a significant predictor of fa-
tigue or sleep problems. This could be related to the fact that
themajority of our population either belonged to an idiopathic
epilepsy group or were well controlled by anti-epileptics.
There is however, also, evidence that all types of seizures
can have the potential for adverse effects on sleep,24 which
may explain why disease severity is not a significant predictor
of sleep problems in our study. Our findings differ from
studies in adults with epilepsy which suggested that the most
important causes of fatigue or sleep problems were energy
consumption depending on the number and/or type of sei-
zures and duration of epilepsy,3,15,23 but these studies did not
explore the effect of illness perceptions.
The present study has some limitations. To start with, the
cross-sectional design does not allow us to draw firm con-
clusions about causality. The generalizability of our findings is
also limited by the strict inclusion criteria that we set in order
to avoid the effect of comorbid physical/mental conditions.
One could also argue that we should have included more
differentiated epilepsy-related factors in our study such as
seizure type, age of seizure onset, seizure frequency and
e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 2 0 ( 2 0 1 6 ) 9 3e9 998duration of epilepsy, but the focus of this studywas on the role
of illness perceptions rather than on predictors that have
already been studied extensively.
Furthermore, there are several other remarks that can be
made with regard to this study. First, we did not include anti-
epileptic drugs (AEDs) as predictors even though they are
known to affect sleep. There is evidence that barbiturates,
benzodiazepines and to a lesser degree phenytoin have
detrimental effects on sleep, while gabapentin, levetiracetam
and lamotrigine have a positive effect on sleep structure. In
general, new generation AEDs have fewer detrimental effects
on sleep structure than the older ones, but measuring the
direct effects of AEDs on sleep and fatigue remains very
difficult because of the many factors that coexist and may
affect this relationship (i.e. type of seizures, polypharmacy,
concurrent sleep disturbances, anxiety, stress etc.).40 We
would like to emphasize however, that there were no AED
changes for at least 6 months prior to the time of measure-
ment and that sleep disturbances were routinely sought after
during follow-up visits in the epilepsy clinic, especially those
possibly related to AEDs (medication or dosage changes).
Next, sleep disorders such as obstructive sleep apnea (OSA)
and periodic limp movements in sleep (PLMS) can often
coexist with epilepsy, may interfere with sleep and some an
extent also with fatigue. In addition, they may affect seizure
control.41,42 Although some general information regarding
these disorders could be drawn from items from the AIS
questionnaire such as sleep induction, awakenings during the
night, overall quality of sleep and sleepiness during the day, in
the present study we did not aim to diagnose these specific
sleep disorders, but mainly focused on the general sleep
quality of our patients. Future studies should also take exist-
ing sleep disturbances into account.
Lastly, we did not measure sleep problems or behaviors of
parents nor didwe take into account their view on their child's
sleep problems or fatigue since our aim was to assess these
concepts by means of a personal report by the youngsters
rather than by proxy perceptions. Nevertheless, it has been
reported that parents have strong concerns about nocturnal
seizures as well as sudden unexplained death.42 Parent-child
co-sleeping has reached rates up to 38%43 and daytime
dysfunction and habitual sleep efficacy have been found to be
the two parental sleep domains with the greatest divergence
between epilepsy and control cohorts. In addition, parents of
children with epilepsy appear to be more fatigued than con-
trols.42 It should however be noted that the majority of these
studies dealt with children with epilepsy that are 10 years old
or younger and that patient inclusion criteria differed from
ours (i.e. co-morbid conditions such as autism spectrum dis-
orders and attention deficit hyperactivity disorder were
included). The influence of parental concerns on sleep and
fatigue in youngsters should however be further explored in
future studies.5. Conclusions
The findings of this study suggest that illness perceptions are
important targets for interventions that aim to reduce fatigue
and sleep problems in youngsters suffering from epilepsy.Most existing interventions focus on seizure reduction rather
than on the reduction of feelings of distress or on other psy-
chological factors such as illness perceptions.44 There are a
fewpromising efforts to develop and implement interventions
for adolescents with epilepsy that combine cognitive-
behavioral approaches and self-management theory,44e46
but these studies do not specifically target fatigue or sleep
problems. As a consequence offering psychological in-
terventions, based on self-regulation theory,47 that aim to
changemaladaptive illness cognitions in youngsters suffering
from epilepsy is an important target for the future.Conflict of interest statement
There is no conflict of interest.
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